Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 54,826 | 27,681 | 124,984 | 87,511 | 55,029 |
| Depreciation Amortization | 29,679 | 13,699 | 7,827 | 5,854 | 3,913 |
| Accounts receivable | -7,427 | -8,794 | -12,293 | -9,347 | -2,918 |
| Accounts payable and accrued liabilities | 11,363 | 4,649 | 2,080 | 5,414 | 1,616 |
| Other Working Capital | 7,413 | -20,906 | -3,652 | 3,164 | -4,030 |
| Other Operating Activity | 5,410 | 7,966 | 32,650 | 15,341 | 8,274 |
| Operating Cash Flow | $101,264 | $24,295 | $151,596 | $107,937 | $61,884 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 75,791 | 2,292 | -75,853 | -12,135 | N/A |
| PPE Investments | -2,494 | -285 | -1,279 | -523 | -161 |
| Net Acquisitions | -542,531 | 81,751 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -9,500 | -1,250 | -4,500 | -3,375 | -2,250 |
| Other Investing Activity | -9,500 | -1,250 | -4,100 | -2,975 | -1,850 |
| Investing Cash Flow | $-478,734 | $82,508 | $-81,232 | $-15,633 | $-2,011 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 450,916 | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | -41,668 | -41,668 | -8,332 |
| Common Stock Issued | 18,573 | 5,160 | 16,419 | 13,468 | 9,411 |
| Other Financing Activity | -19,061 | -23,385 | -7,833 | -7,683 | -3,350 |
| Financing Cash Flow | $450,428 | $-18,225 | $-33,082 | $-35,883 | $-2,271 |
| Exchange Rate Effect | -491 | 0 | N/A | 0 | N/A |
| Beginning Cash Position | 82,076 | 82,076 | 44,794 | 44,794 | 44,794 |
| End Cash Position | 154,543 | 170,654 | 82,076 | 101,215 | 102,396 |
| Net Cash Flow | $72,467 | $88,578 | $37,282 | $56,421 | $57,602 |
| Free Cash Flow | |||||
| Operating Cash Flow | 101,264 | 24,295 | 151,596 | 107,937 | 61,884 |
| Capital Expenditure | -2,494 | -285 | -1,279 | -523 | -161 |
| Free Cash Flow | 98,770 | 24,010 | 150,317 | 107,414 | 61,723 |